Torin 1

Catalog No.S2827

Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.

Price Stock Quantity  
USD 170 In stock
USD 370 In stock
USD 670 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Torin 1 Chemical Structure

Torin 1 Chemical Structure
Molecular Weight: 607.62

Validation & Quality Control

4 customer reviews :

Quality Control & MSDS

Related Compound Libraries

mTOR Inhibitors with Unique Features

Product Information

  • Compare mTOR Inhibitors
    Compare mTOR Products
  • Research Area
  • Combination Therapy
    Combination Therapy

Product Description

Biological Activity

Description Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays; exhibits 1000-fold selectivity for mTOR than PI3K.
Targets mTORC1 [1]
(Cell-free assay)
mTOR [2]
(Cell-free assay)
DNA-PK [2]
(Cell-free assay)
mTORC2 [1]
(Cell-free assay)

 View  More

IC50 2 nM 4.32 nM 6.34 nM 10 nM
In vitro Torin1 inhibits phosphorylation of mTORC1 and mTORC2 substrates in cells at concentrations of 2 and 10 nM, respectively. Moreover, Torin1 exhibits 1000-fold selectivity for mTOR over PI3K (EC50 = 1800 nM) and exhibits 100-fold binding selectivity relative to 450 other protein kinases. [1] [2] Torin1 causes cell cycle arrest through a rapamycin-resistant mechanism that is also independent of mTORC2. Torin1 disrupts mTORC1-dependent phenotypes more completely than rapamycin. Rapamycin-resistant functions of mTORC1 are required for cap-dependent translation. [1] In a recent study, it is reported Torin1 increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. [3]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
ETK-1MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;UTWM2OD1yLkCwNFMxPiEQvF2=MX\TRW5ITVJ?
OCUB-MNFrCWGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml[wTWM2OD1yLkCwNVk1KM7:TR?=MWfTRW5ITVJ?
DOHH-2NF7HfoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYXJR|UxRTBwMECyNlUh|ryPNHe2U|FUSU6JRWK=
NOS-1NIroeG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrETWM2OD1yLkCwNlQzKM7:TR?=M{DHbnNCVkeHUh?=
L-363NGWzeZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYfJR|UxRTBwMECyPFQh|ryPMmn5V2FPT0WU
RL95-2MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4jad2lEPTB;MD6wNFMzKM7:TR?=M3LYWnNCVkeHUh?=
BL-70MnThS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTBwMECzN|ch|ryPMkfFV2FPT0WU
TGBC1TKBMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoTvTWM2OD1yLkCwN|c6KM7:TR?=NI\UVmlUSU6JRWK=
697MoKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4S1dGlEPTB;MD6wNFY{PCEQvF2=MX;TRW5ITVJ?
RPMI-8226M4mzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWTUVllYUUN3ME2wMlAxPjVzIN88US=>MlLNV2FPT0WU
BL-41MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV7JR|UxRTBwMEC2PVYh|ryPMVvTRW5ITVJ?
MRK-nu-1MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4j4fWlEPTB;MD6wNFcxPyEQvF2=NWLhbo9bW0GQR1XS
EW-1NFjpNJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVrJR|UxRTBwMEC3OFkh|ryPNIS5WXBUSU6JRWK=
EVSA-TM{PoTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml73TWM2OD1yLkCwPFkzKM7:TR?=NVjZflZqW0GQR1XS
HUTU-80MkPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlH1TWM2OD1yLkCwPVI6KM7:TR?=M2r5PXNCVkeHUh?=
VA-ES-BJNFPMcmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{HsN2lEPTB;MD6wNFk5PCEQvF2=NXPjNlY5W0GQR1XS
GCIYM4r2dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHvbG9KSzVyPUCuNFExODdizszNNI\JOYZUSU6JRWK=
ES6NEjGSZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmPuTWM2OD1yLkCxNFg{KM7:TR?=MX7TRW5ITVJ?
NALM-6NEDBd5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEC1U21KSzVyPUCuNFEyODJizszNNUnsb4FwW0GQR1XS
LB996-RCCNWrDeVlbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGm1c2dKSzVyPUCuNFEyOzdizszNNF6xe4JUSU6JRWK=
EW-16NV\6XpZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVLJR|UxRTBwMEGxPVIh|ryPNX3HfZlkW0GQR1XS
KALS-1M1qwc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVvJR|UxRTBwMEGxPVgh|ryPNWTsNW13W0GQR1XS
OPM-2NFnSdmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkG1TWM2OD1yLkCxNlkh|ryPMkLPV2FPT0WU
KU812MoDHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYPJR|UxRTBwMEGyPVYh|ryPNFnMdYVUSU6JRWK=
A4-FukMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVTJR|UxRTBwMEGzNVkh|ryPNWLMe2MyW0GQR1XS
KGNNUDJVlA4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlXBTWM2OD1yLkCxN|U6KM7:TR?=NVjiVVRXW0GQR1XS
KS-1MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEfPdoJKSzVyPUCuNFE{QTJizszNNVXjVnR6W0GQR1XS
no-11MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;1dnlpUUN3ME2wMlAyOzl3IN88US=>NVTFNmNPW0GQR1XS
PSN1NFrrOGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmrXTWM2OD1yLkCxOFA6KM7:TR?=NYX1[|dUW0GQR1XS
SK-LMS-1MkjJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPldm9rUUN3ME2wMlAyPDF|IN88US=>M1HxXHNCVkeHUh?=
LS-411NNE\z[ZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGDveIpKSzVyPUCuNFE1OzlizszNMlfnV2FPT0WU
HT-144MmD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWPvVndLUUN3ME2wMlAyPDVzIN88US=>M3LPPXNCVkeHUh?=
ACNMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTBwMEG1JO69VQ>?NGHJenZUSU6JRWK=
RKONGK0SIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTBwMEG1N|Mh|ryPMkLTV2FPT0WU
CMKMXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2ntT2lEPTB;MD6wNVU1OyEQvF2=NYLpbIF4W0GQR1XS
GB-1MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mnv3TWM2OD1yLkCxOVU{KM7:TR?=MoLUV2FPT0WU
KE-37MkPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUXFd5N5UUN3ME2wMlAyPTd|IN88US=>MlTYV2FPT0WU
no-10MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGrseZpKSzVyPUCuNFE2QDRizszNNI\UfXNUSU6JRWK=
MOLT-16M2\PcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfJSZVGUUN3ME2wMlAyPjJ{IN88US=>Mn;GV2FPT0WU
HELNVLqW|k3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEPrb5hKSzVyPUCuNFE3PCEQvF2=MVnTRW5ITVJ?
NCI-H1355NV3tT5ZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M37zeWlEPTB;MD6wNVY1PiEQvF2=MnrnV2FPT0WU
IST-MEL1M2H4[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\TTWM2OD1yLkCxO|c1KM7:TR?=MYLTRW5ITVJ?
MHH-PREB-1NInqSopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF7sXoVKSzVyPUCuNFE5OThizszNM3fTSXNCVkeHUh?=
ES8NWG5dYhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYDJR|UxRTBwMEG4OFQh|ryPNIHkSW1USU6JRWK=
LC-2-adMmPYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIjlcWFKSzVyPUCuNFIyOzdizszNMmXzV2FPT0WU
LAMA-84NXnZXnI2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVT6XJVpUUN3ME2wMlAzOTZ5IN88US=>MXrTRW5ITVJ?
BV-173MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnE[phKSzVyPUCuNFIzODNizszNNV7pXnBjW0GQR1XS
SW872MlfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1S5bGlEPTB;MD6wNlI1PyEQvF2=MUnTRW5ITVJ?
SK-UT-1NIHZUHpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NI\HXFlKSzVyPUCuNFIzPjFizszNMl7NV2FPT0WU
OS-RC-2NIrGXldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13MXGlEPTB;MD6wNlMzOyEQvF2=NYDZ[JJMW0GQR1XS
NCI-H747NFfkWI9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoP1TWM2OD1yLkCyN|Mh|ryPM1eycnNCVkeHUh?=
MZ2-MELM3Hyemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEi4[mNKSzVyPUCuNFI{OzdizszNMnzCV2FPT0WU
TE-11NFrsPYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWLFTmdpUUN3ME2wMlAzOzd{IN88US=>MWPTRW5ITVJ?
KURAMOCHIMknHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnVd2dKSzVyPUCuNFI1OTRizszNMYTTRW5ITVJ?
HD-MY-ZM4\vOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1uyRmlEPTB;MD6wNlQzPiEQvF2=MYXTRW5ITVJ?
GI-1NELkV3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkjqTWM2OD1yLkCyOFY6KM7:TR?=MkDtV2FPT0WU
LB1047-RCCM1HCPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTBwMEK0PFgh|ryPNHLEV45USU6JRWK=
TE-12MkniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVPJR|UxRTBwMEK1OUDPxE1?MXLTRW5ITVJ?
MZ7-melMX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYixZmVQUUN3ME2wMlAzPjB7IN88US=>NVnlcIpsW0GQR1XS
MMAC-SFNYjZVoJXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYmyd2hlUUN3ME2wMlAzPjN|IN88US=>NUXJdWxJW0GQR1XS
A101DNEewZpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17rW2lEPTB;MD6wNlY2KM7:TR?=M2nPOHNCVkeHUh?=
GR-STMYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NITFb2hKSzVyPUCuNFI3PTVizszNM3Xr[HNCVkeHUh?=
MC116NFTp[ohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFy4c4lKSzVyPUCuNFI3QCEQvF2=NW\y[XNQW0GQR1XS
Ramos-2G6-4C10MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFXpWYdKSzVyPUCuNFI4PSEQvF2=NWTaN4tEW0GQR1XS
ATN-1NV3S[25OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIf6WGJKSzVyPUCuNFI4QDlizszNM{LQV3NCVkeHUh?=
MFH-inoNXvGfXNtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoWzTWM2OD1yLkCyPFEzKM7:TR?=MUHTRW5ITVJ?
DELM4j6d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVS5ZndCUUN3ME2wMlAzQDF3IN88US=>NHLNWYlUSU6JRWK=
OCI-AML2MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn74TWM2OD1yLkCyPFcyKM7:TR?=M4\3VnNCVkeHUh?=
LXF-289M1;Pdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYTJR|UxRTBwMEK4O|Ih|ryPNGLzNmNUSU6JRWK=
IA-LMMl;BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFXubm9KSzVyPUCuNFI6OTdizszNNX2wd|BlW0GQR1XS
EoL-1-cellM3fWR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlnTTWM2OD1yLkCyPVk3KM7:TR?=NFPjeHJUSU6JRWK=
OVCAR-4Ml\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTBwMEOwPVQh|ryPM{K4dnNCVkeHUh?=
ES1MkXpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{HyfmlEPTB;MD6wN|A6PyEQvF2=M1vkNHNCVkeHUh?=
CESSM2PJbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXjLdph2UUN3ME2wMlA{ODl7IN88US=>NIPYZYhUSU6JRWK=
GAKNEjWb2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVP5ZYsyUUN3ME2wMlA{OTh4IN88US=>MkPwV2FPT0WU
NTERA-S-cl-D1NHznRWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mle4TWM2OD1yLkCzNlI3KM7:TR?=NVT6fIdQW0GQR1XS
TE-10MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXfKdYNtUUN3ME2wMlA{OzFzIN88US=>NGrM[WtUSU6JRWK=
CCRF-CEMMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3v4e2lEPTB;MD6wN|M4OSEQvF2=NFPFZWtUSU6JRWK=
NMC-G1NFLoW3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NG\Zd5FKSzVyPUCuNFM1PDhizszNMnjsV2FPT0WU
HOP-62M3TJbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M364[WlEPTB;MD6wN|U2PiEQvF2=M3;oe3NCVkeHUh?=
SH-4MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjNV|VGUUN3ME2wMlA{PTh{IN88US=>MmXNV2FPT0WU
NCI-H1648NEXKdW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIfSdpRKSzVyPUCuNFM3OjJizszNM2XH[XNCVkeHUh?=
EB-3NIPvSHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmHUTWM2OD1yLkCzOlQ{KM7:TR?=NWq3SFh7W0GQR1XS
BB65-RCCNF60WIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{\TXGlEPTB;MD6wN|Y6OSEQvF2=NWLySJNkW0GQR1XS
BE-13NFHwPVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGe5VIxKSzVyPUCuNFM4PTlizszNNH3UU5RUSU6JRWK=
CP67-MELNVnHSHRiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3S2[mlEPTB;MD6wN|c2QSEQvF2=MkXYV2FPT0WU
SW954MlnwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXvJR|UxRTBwMEO3PUDPxE1?MoLEV2FPT0WU
TE-5M3q4dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH3pfYtKSzVyPUCuNFM5PTRizszNMYfTRW5ITVJ?
HCE-4M1vTTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVPZS5NqUUN3ME2wMlA{QDV3IN88US=>Mn;zV2FPT0WU
LC-1FM3Pmfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFLUT4hKSzVyPUCuNFM6QDlizszNMVzTRW5ITVJ?
TK10MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXyybXFPUUN3ME2wMlA1ODF7IN88US=>MmPvV2FPT0WU
SJSA-1M4HtZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{LHTGlEPTB;MD6wOFE5QCEQvF2=MVvTRW5ITVJ?
DaudiMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml36TWM2OD1yLkC0NlI2KM7:TR?=M1T5T3NCVkeHUh?=
SW982M{PTVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWXiSpp5UUN3ME2wMlA1OjR4IN88US=>MmPHV2FPT0WU
SF126M1rmZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUfET3l2UUN3ME2wMlA1OzZzIN88US=>MWPTRW5ITVJ?
TE-15NGHLeZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofHTWM2OD1yLkC0OFM2KM7:TR?=MXfTRW5ITVJ?
COLO-684MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUDGfZNIUUN3ME2wMlA1PTZzIN88US=>NHTwc3BUSU6JRWK=
8-MG-BAMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2Oxd2lEPTB;MD6wOFYzQSEQvF2=MUXTRW5ITVJ?
NB13MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMES3O|Yh|ryPNV7GeGNnW0GQR1XS
HCC1599NH\SWpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEPC[pZKSzVyPUCuNFQ5PzlizszNNXf1[5BXW0GQR1XS
SK-PN-DWNUTWbnN4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXaSlNnUUN3ME2wMlA1QTR7IN88US=>MWfTRW5ITVJ?
ALL-PONVP3XIlTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3P6XWlEPTB;MD6wOFk2PiEQvF2=M4jmfHNCVkeHUh?=
NB6NWn4SnV6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXLLZ25VUUN3ME2wMlA2OjdzIN88US=>MVfTRW5ITVJ?
IST-SL2M1LxZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnKXnpKSzVyPUCuNFU{PjJizszNMXrTRW5ITVJ?
BB30-HNCMoPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnztTWM2OD1yLkC1O|Mh|ryPMV\TRW5ITVJ?
SW962NELsbHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXfJR|UxRTBwMEW3OlMh|ryPMXHTRW5ITVJ?
TGBC24TKBNIjrS|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTBwMEW3PVkh|ryPMm\0V2FPT0WU
KINGS-1MnXZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFTiNWZKSzVyPUCuNFU5ODNizszNM4S1UXNCVkeHUh?=
HC-1NYnLVZU6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWjJR|UxRTBwMEW4Nlch|ryPM3LNVnNCVkeHUh?=
RS4-11MkXqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXfJR|UxRTBwMEW5N|gh|ryPMmP1V2FPT0WU
LS-123NUDYU5U2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTBwMEW5OFIh|ryPM4fSOHNCVkeHUh?=
A3-KAWM2m0cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnTTTWM2OD1yLkC2NlI2KM7:TR?=M3rVcnNCVkeHUh?=
SNB75MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnRWnVKSzVyPUCuNFY{PDFizszNMkfNV2FPT0WU
SRNEnEdFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUHJR|UxRTBwME[zO|Qh|ryPNGfHXIFUSU6JRWK=
LOUCYMWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnpSoxKSzVyPUCuNFY{QTRizszNMofVV2FPT0WU
K5NIPB[YxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2C2RWlEPTB;MD6wOlQxOyEQvF2=M2nFfHNCVkeHUh?=
BeckerMYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MULJR|UxRTBwME[0NkDPxE1?MWjTRW5ITVJ?
CTV-1MoXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoH2TWM2OD1yLkC2OVQ5KM7:TR?=NGfBfW1USU6JRWK=
KLEMWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn\rTWM2OD1yLkC2OVg1KM7:TR?=MWnTRW5ITVJ?
MZ1-PCNF3DeXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXrJR|UxRTBwME[1PVgh|ryPMWnTRW5ITVJ?
MOLT-4NILTRZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWnDUHVSUUN3ME2wMlA3PjB3IN88US=>NFy1cGhUSU6JRWK=
MLMAMlHUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4HFRmlEPTB;MD6wOlc5KM7:TR?=NXHHZ3JnW0GQR1XS
A388M2i5fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoGxTWM2OD1yLkC2PFk{KM7:TR?=MmX1V2FPT0WU
MV-4-11NHL3N2lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWjzXnJrUUN3ME2wMlA3QTl3IN88US=>MXTTRW5ITVJ?
DSH1M1HQXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYDJR|UxRTBwMEexO|Mh|ryPNVe5[nc1W0GQR1XS
MONO-MAC-6M1S3Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml;DTWM2OD1yLkC3NlEzKM7:TR?=M33zXHNCVkeHUh?=
ARH-77NHP6N|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYjtWmVbUUN3ME2wMlA4Ojd6IN88US=>M3\KbnNCVkeHUh?=
LB771-HNCMlHjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvRcG1KSzVyPUCuNFc2PDlizszNMXzTRW5ITVJ?
PF-382MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXkNHRwUUN3ME2wMlA4PTZ7IN88US=>Ml3hV2FPT0WU
KM12NIDIcGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX;BfmQ1UUN3ME2wMlA4PjRizszNM1LsS3NCVkeHUh?=
HAL-01M2WwRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXTJR|UxRTBwMEe2OVgh|ryPMV3TRW5ITVJ?
RPMI-8402MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHJTWM2OD1yLkC3O|g6KM7:TR?=MWDTRW5ITVJ?
OMC-1M1PlU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2PWUGlEPTB;MD6wO|gxPCEQvF2=NILMWGRUSU6JRWK=
HTNYHoPIV{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEHJeHFKSzVyPUCuNFgh|ryPNEDBPGVUSU6JRWK=
QIMR-WILM3L0emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\QTWM2OD1yLkC4NFU2KM7:TR?=NUPTWYlnW0GQR1XS
KNS-42MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnHUTWM2OD1yLkC4NlA{KM7:TR?=MXrTRW5ITVJ?
BC-3NYr6cHdxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH35fIhKSzVyPUCuNFgzODRizszNNHvPO4hUSU6JRWK=
ES4M1vqZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7oTWM2OD1yLkC4Nlk3KM7:TR?=MWjTRW5ITVJ?
NCI-H23MoT5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIDw[YFKSzVyPUCuNFg1PCEQvF2=NFXCflJUSU6JRWK=
LB2518-MELM4TFWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjkcVhKSzVyPUCuNFg3QTZizszNNG\E[ZhUSU6JRWK=
LC4-1NF3JT4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkT4TWM2OD1yLkC4O|M5KM7:TR?=M2HPNnNCVkeHUh?=
SIG-M5MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2jVW2lEPTB;MD6wPFkxPCEQvF2=NXHBO|A2W0GQR1XS
LP-1M1v5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NILPPVBKSzVyPUCuNFg6OzhizszNMoXxV2FPT0WU
TE-8MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPXOJN5UUN3ME2wMlA6ODF4IN88US=>NYX0XXBMW0GQR1XS
K-562MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHnJWYJKSzVyPUCuNFkyOiEQvF2=MmG0V2FPT0WU
J-RT3-T3-5MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;HTWM2OD1yLkC5NVU{KM7:TR?=MYHTRW5ITVJ?
DU-4475MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XrfGlEPTB;MD6wPVE3PSEQvF2=MluwV2FPT0WU
RXF393MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTVT4RYUUN3ME2wMlA6PDZ{IN88US=>MWHTRW5ITVJ?
NB5M{LDN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHyzVG5KSzVyPUCuNFk3OjVizszNNV\1dWRvW0GQR1XS
A704M1i0eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnHiTWM2OD1yLkC5O|QyKM7:TR?=Mn6yV2FPT0WU
SF268MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrSVXpKSzVyPUCuNFk5OjVizszNNVXxelY2W0GQR1XS
UACC-257M1rXNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLGSFlTUUN3ME2wMlA6QDN|IN88US=>NVnDUphMW0GQR1XS
L-428MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4H5SGlEPTB;MD6xNFMzKM7:TR?=NFPaOYJUSU6JRWK=
ST486NFK2RphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXHzR3h7UUN3ME2wMlExPjB4IN88US=>M3TWUnNCVkeHUh?=
SK-MM-2NIDSbopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTBwMUC3NFkh|ryPNYGzUHVwW0GQR1XS
COR-L279MoHLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmTaTWM2OD1yLkGwPFMzKM7:TR?=MnfmV2FPT0WU
JiyoyeP-2003M{fobmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIHRUmZKSzVyPUCuNVA5PDNizszNMWjTRW5ITVJ?
GT3TKBMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVGyR45NUUN3ME2wMlExQTF6IN88US=>NG\IemNUSU6JRWK=
HCE-TM2XW[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVW0c5liUUN3ME2wMlExQTRizszNNWrGVlR2W0GQR1XS
SBC-1MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\vTWM2OD1yLkGxNVE6KM7:TR?=Mm[1V2FPT0WU
KNS-81-FDMV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MU\JR|UxRTBwMUGyO|Mh|ryPM1T5Z3NCVkeHUh?=
NCI-H2126MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFnuUVhKSzVyPUCuNVE{QTRizszNMXXTRW5ITVJ?
EM-2MmjQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTBwMUG1Nlkh|ryPM4TtW3NCVkeHUh?=
JARM3HMWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3zXSGlEPTB;MD6xNVU6QCEQvF2=NXHwPY1OW0GQR1XS
NB17M1;hTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{TjcGlEPTB;MD6xNVY2OiEQvF2=M4TJNHNCVkeHUh?=
LB647-SCLCMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\zfXlrUUN3ME2wMlEyPzB3IN88US=>M3O0dHNCVkeHUh?=
CAL-148MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1TicmlEPTB;MD6xNVgh|ryPNHXPOGNUSU6JRWK=
K052MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1PUcmlEPTB;MD6xNVg2OSEQvF2=M{nDPXNCVkeHUh?=
KARPAS-299M2HtT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2TBV2lEPTB;MD6xNlI{OyEQvF2=MVzTRW5ITVJ?
KARPAS-422MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NG\oZllKSzVyPUCuNVI1OzJizszNMlPXV2FPT0WU
LOXIMVINVXNNJZvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYrJR|UxRTBwMUK1NVUh|ryPNFi5No1USU6JRWK=
SCC-3Moj6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3O4[GlEPTB;MD6xNlg2OSEQvF2=MXvTRW5ITVJ?
LU-139NFLTUJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVnJR|UxRTBwMUK5O|Uh|ryPNWjsVIVSW0GQR1XS
COLO-320-HSRM4i3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXHJR|UxRTBwMUOwPFYh|ryPNFnnfpNUSU6JRWK=
ONS-76MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfZTWM2OD1yLkGzNVMh|ryPM4HQc3NCVkeHUh?=
U-266MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVGxOmVIUUN3ME2wMlE{OjR3IN88US=>MYXTRW5ITVJ?
HHNVnXOmlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXvXZ5hjUUN3ME2wMlE{PTN3IN88US=>M{fueHNCVkeHUh?=
BB49-HNCMYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTBwMUO1PFch|ryPNX\vVHFOW0GQR1XS
NCI-SNU-5MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmnDTWM2OD1yLkGzOVk3KM7:TR?=MULTRW5ITVJ?
C2BBe1MkjBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUCybHQxUUN3ME2wMlE{PzR4IN88US=>NV22VplVW0GQR1XS
ML-2MmmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVXiOXlJUUN3ME2wMlE{QTV|IN88US=>MXnTRW5ITVJ?
SCHMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NU\Dd29KUUN3ME2wMlE{QTd2IN88US=>MX7TRW5ITVJ?
NCI-H82MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mor0TWM2OD1yLkG0NVA1KM7:TR?=MXnTRW5ITVJ?
MDA-MB-134-VIM{\ZZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTBwMUSyOVIh|ryPMl\iV2FPT0WU
SK-N-DZM4D1U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\QTWM2OD1yLkG0O|E6KM7:TR?=M3v1d3NCVkeHUh?=
HL-60MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWTyUHY6UUN3ME2wMlE1QTJizszNNYK3OoFzW0GQR1XS
LB373-MEL-DNVHRUmhIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml24TWM2OD1yLkG1OVM6KM7:TR?=MoTCV2FPT0WU
LB831-BLCNFPOc3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFXLTVJKSzVyPUCuNVYxPzZizszNM2TRc3NCVkeHUh?=
SK-NEP-1Ml;3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGD5fYFKSzVyPUCuNVYyODFizszNNILPb5lUSU6JRWK=
IMR-5NYD2O21DT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{D0ZmlEPTB;MD6xOlQ5OyEQvF2=MkjSV2FPT0WU
Calu-6M4fYTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NY\FSVhOUUN3ME2wMlE3PTN5IN88US=>NYHlSGwxW0GQR1XS
NCI-H1882M2jDbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NF3u[HVKSzVyPUCuNVY4OjhizszNNFnZe4hUSU6JRWK=
NCI-H446NGDLUmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYm1UoFbUUN3ME2wMlE3QDlzIN88US=>M4nXcHNCVkeHUh?=
GI-ME-NNVjDOYRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1vKTmlEPTB;MD6xPFAzKM7:TR?=M4rWVXNCVkeHUh?=
MPP-89Mn;0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYfzeHpJUUN3ME2wMlE5OTJzIN88US=>MUXTRW5ITVJ?
CGTH-W-1M2n2[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTBwMUi0N|Yh|ryPM{KxN3NCVkeHUh?=
MEG-01MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M33wWGlEPTB;MD6xPFYzQCEQvF2=MXjTRW5ITVJ?
NCI-H748M4LTNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1ezUWlEPTB;MD6xPFkyOSEQvF2=M37TXHNCVkeHUh?=
COLO-829NGD4UnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTBwMkC2O|Mh|ryPMkP5V2FPT0WU
GOTOMWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXLqdJZ2UUN3ME2wMlIxPzNizszNNVrGcppTW0GQR1XS
EW-3M{fmcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnzwTWM2OD1yLkKxO|E5KM7:TR?=NH7yXVFUSU6JRWK=
KY821Mk\DS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{\p[2lEPTB;MD6yNlA1PSEQvF2=NH[yTW9USU6JRWK=
CTB-1MlL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmC0TWM2OD1yLkKyNlI5KM7:TR?=MX\TRW5ITVJ?
TALL-1NVvYepBZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUjE[Yh1UUN3ME2wMlIzQTJzIN88US=>MV7TRW5ITVJ?
NCI-H209M4DVR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlrDTWM2OD1yLkKyPVYzKM7:TR?=MVPTRW5ITVJ?
IST-MES1M3LrRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvuTWM2OD1yLkKzOVEh|ryPMnLRV2FPT0WU
DMS-114MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\pTWM2OD1yLkKzPVk{KM7:TR?=NUXofVFlW0GQR1XS
SNU-C2BNYS3UXhNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NF\nUWFKSzVyPUCuNlQ{OTZizszNMVrTRW5ITVJ?
DG-75M33aTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1XRNGlEPTB;MD6yOlE6PSEQvF2=M{i1Z3NCVkeHUh?=
D-336MGNUDSRoIzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4D6XmlEPTB;MD6yOlU2PyEQvF2=NX;qblBFW0GQR1XS
KMOE-2NFS5dYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{LQWGlEPTB;MD6yO|U{QCEQvF2=NUiwSo96W0GQR1XS
NB1NIP0bpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17BeGlEPTB;MD6yO|kzPiEQvF2=MoXLV2FPT0WU
RH-1NXTJRmJ7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWHITJY{UUN3ME2wMlI4QTh7IN88US=>NUXKb4Z5W0GQR1XS
TE-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIXyOWJKSzVyPUCuNlg1PzlizszNMVvTRW5ITVJ?
RPMI-6666NX\CVGFkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NG\sNVlKSzVyPUCuNlg5PCEQvF2=NE[1c4dUSU6JRWK=
TE-9Mo\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYDnco1{UUN3ME2wMlI5QTh3IN88US=>NELXO2NUSU6JRWK=
BT-474MkjIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWnYVGNNUUN3ME2wMlI6OzN2IN88US=>NXTmSndvW0GQR1XS
COLO-668M4L5eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4L1bWlEPTB;MD6yPVQzQSEQvF2=NXHY[49QW0GQR1XS
NCI-H1581M4nvbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1jFOGlEPTB;MD6yPVY5QSEQvF2=M3;rR3NCVkeHUh?=
MN-60Ml60S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2n4SWlEPTB;MD6yPVkxPSEQvF2=NWHZNlF1W0GQR1XS
L-540NUO1SGpNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPoTWM2OD1yLkOwNFgyKM7:TR?=NVnrVVBqW0GQR1XS
MOLT-13MkfIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1WyO2lEPTB;MD6zNFE5OyEQvF2=MnnBV2FPT0WU
NCI-SNU-16MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NV;oW45rUUN3ME2wMlMxOjB3IN88US=>NXTkdZBmW0GQR1XS
NCI-H64NGm1RmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTBwM{CzN|Eh|ryPNV35fY05W0GQR1XS
CP66-MELNWHPUWZqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTBwM{G0NVUh|ryPNGO2U4FUSU6JRWK=
NB69MkG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkjYTWM2OD1yLkOyNVg5KM7:TR?=NF;rWolUSU6JRWK=
NCI-H2196MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUXJR|UxRTBwM{OwN|Yh|ryPNXfwT3NnW0GQR1XS
MHH-CALL-2NEj4fY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF3yN3lKSzVyPUCuN|M1PjhizszNM4G3eHNCVkeHUh?=
HCC2157M1;DXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUn4UpM4UUN3ME2wMlM{QTV2IN88US=>M3fPPHNCVkeHUh?=
LS-1034MonTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXvZXVJ5UUN3ME2wMlM3Ozh6IN88US=>MmTwV2FPT0WU
BOKUNGfkXnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlL5TWM2OD1yLkO3NVk6KM7:TR?=M2S4eXNCVkeHUh?=
GDM-1NWPsVWI1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXv0PGNwUUN3ME2wMlM4OjN2IN88US=>MX;TRW5ITVJ?
TGWM3TEOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3HjbmlEPTB;MD6zO|Q2OyEQvF2=M1LQU3NCVkeHUh?=
SNU-C1NH7xcHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2\BdmlEPTB;MD6zPFIyPSEQvF2=NU\NWm1VW0GQR1XS
LS-513NH\2T4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NIrkWm1KSzVyPUCuN|kxPzFizszNNX;NVYd2W0GQR1XS
NOMO-1NFzBT5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUnJclRNUUN3ME2wMlM6QTdzIN88US=>NUDRSo5pW0GQR1XS
MS-1MnPuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2nkUGlEPTB;MD60NFE4PyEQvF2=MkThV2FPT0WU
EKVXMkmzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4nPS2lEPTB;MD60OFQ3OSEQvF2=MVnTRW5ITVJ?
SK-MEL-2MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELoUIFKSzVyPUCuOFY1KM7:TR?=MVrTRW5ITVJ?
HCC1187MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHq3WYlKSzVyPUCuOFY4PjhizszNMoDzV2FPT0WU
HCC2218MmDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX;JV5JqUUN3ME2wMlQ4OjJ5IN88US=>NXS1[nVYW0GQR1XS
NCI-H187NWPNeXR7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlPmTWM2OD1yLkS3PFQh|ryPM3zzW3NCVkeHUh?=
DBMUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NEnidGFKSzVyPUCuOVAxPTVizszNMlXwV2FPT0WU
NCI-H69M{Pub2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEXk[4NKSzVyPUCuOVAzPDdizszNM1ixSXNCVkeHUh?=
NCI-H1694NUSzZXlCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWfmNGVoUUN3ME2wMlUxPjl5IN88US=>NU\RcXJlW0GQR1XS
CA46MoW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRTBwNUC5NVch|ryPNHTq[mtUSU6JRWK=
EHEBMVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjrTWM2OD1yLkWxNVk{KM7:TR?=MVvTRW5ITVJ?
NCCITNVPYTYFUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NW\3[ZpCUUN3ME2wMlU1OzJzIN88US=>MXXTRW5ITVJ?
NCI-H720M3\NR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX\JR|UxRTBwNUS5OlIh|ryPNX:yTYpwW0GQR1XS
LU-134-AMl\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2[1OWlEPTB;MD61OVI6PiEQvF2=M4jrW3NCVkeHUh?=
MC-CARM1vxcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkLVTWM2OD1yLkW1OFMyKM7:TR?=MYnTRW5ITVJ?
NEC8NHTZcXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGCwRYxKSzVyPUCuOVYyPzJizszNNF\BTIlUSU6JRWK=
NCI-H524M2nHc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUjJR|UxRTBwNUi3OFgh|ryPNFH0ZXhUSU6JRWK=
NCI-H1963NXn0cll3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoDkTWM2OD1yLk[yOVgh|ryPMUjTRW5ITVJ?
SU-DHL-1M3PnXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXPJR|UxRTBwNkS1NlYh|ryPMVPTRW5ITVJ?
NCI-H1522M{HEXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mnj0TWM2OD1yLk[0PFg{KM7:TR?=NGDrc3ZUSU6JRWK=
NCI-H1155MlP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWD4WIR[UUN3ME2wMlY2OzVizszNM1\3WnNCVkeHUh?=
D-263MGNHPrXpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHIbHlZUUN3ME2wMlY3OTBzIN88US=>NXrOV2NqW0GQR1XS
TE-6NU\Gb2ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2joSmlEPTB;MD62PFExPCEQvF2=M1;uSXNCVkeHUh?=
NCI-H1417NIK0S|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXjJR|UxRTBwNkm3NVEh|ryPNH:5[3BUSU6JRWK=
NCI-H510ANXPmPZhrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHnbIQ6UUN3ME2wMlc4OjN4IN88US=>MV;TRW5ITVJ?
KARPAS-45NYnIU5NuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXzTWM2OD1yLke4NlM2KM7:TR?=NHnJPWZUSU6JRWK=
IST-SL1M3nvNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVTJR|UxRTBwOEW4NlUh|ryPNVSxdG9zW0GQR1XS
COLO-824NVLMdo5iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFnaclBKSzVyPUCuPFc5OzVizszNNW[2d5MxW0GQR1XS
NCI-H526NXLheFByT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1Lw[WlEPTB;MD65NFk2QCEQvF2=M1nlO3NCVkeHUh?=
NCI-H719M2nxOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFvESWRKSzVyPUCuPVY3PTdizszNMXfTRW5ITVJ?
SF539M1PkTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUXJR|UxRTBwOUizPVYh|ryPMWLTRW5ITVJ?
NKM-1NGC4[5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfw[5hKSzVyPUCuPVg3PjNizszNMXjTRW5ITVJ?
A253NGLMVXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYTDZVVPUUN3ME2wMlk5QDh3IN88US=>M1rnZ3NCVkeHUh?=
TE-441-TMkD1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmjZTWM2OD1zLkC0N|Uh|ryPMoTCV2FPT0WU
COR-L88M2raVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVPJR|UxRTFwMUGzOVQh|ryPNIK3O4dUSU6JRWK=
CPC-NNHnR[I5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWHpVWJXUUN3ME2xMlE2QDh6IN88US=>NVPJdVREW0GQR1XS
NCI-H2107MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF;xSWFKSzVyPUGuNVczPjFizszNNFn5O5lUSU6JRWK=
ECC4MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\3TWM2OD1zLkG4Olk{KM7:TR?=NHvVSmJUSU6JRWK=
NCI-H2141NH\NXllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{fRcGlEPTB;MT6xPVI6QSEQvF2=MVXTRW5ITVJ?
NCI-H1770MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvtV2hmUUN3ME2xMlMzQTJ6IN88US=>Ml3rV2FPT0WU
NCI-SNU-1MkPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVXJR|UxRTFwM{OwOEDPxE1?MnTjV2FPT0WU
LU-165MlzUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3noZ2lEPTB;MT60OVQ3PyEQvF2=NVHQV3NJW0GQR1XS
RajiMVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NF7xTFVKSzVyPUGuOFczPTlizszNNVXmdFJmW0GQR1XS
EW-24MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Ml\MTWM2OD1zLkW0OlE6KM7:TR?=MmjzV2FPT0WU
KP-N-RT-BM-1NHzldXVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2L0[2lEPTB;MT61OlU2OSEQvF2=MmHZV2FPT0WU
SK-MEL-1MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXHTWM2OD1zLk[0PFc4KM7:TR?=NXXYbZRCW0GQR1XS
SCLC-21HM2ezZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTFwNk[2OVEh|ryPNYXyS3VrW0GQR1XS
SIMAM173NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmXMTWM2OD1zLk[4NlM{KM7:TR?=MlTMV2FPT0WU
NCI-H1304MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUW0Z5RXUUN3ME2xMlcxPzZ3IN88US=>NV7WfnBHW0GQR1XS
REHNFLhRVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYDtS2NNUUN3ME2xMlcyODd6IN88US=>MnLiV2FPT0WU
KP-N-YSMnL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGq5XVdKSzVyPUGuPVM2PTFizszNNYfES2hDW0GQR1XS
DMS-153Mn70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHTKWJNKSzVyPUGuPVc2QSEQvF2=MmH4V2FPT0WU
NB10NFT5RVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2C5S2lEPTB;Mj6yNFg4QCEQvF2=MmXtV2FPT0WU
NCI-H345M1SyOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTsRWVIUUN3ME2yMlYyQTB3IN88US=>NY\zXGNMW0GQR1XS
SK-N-FIMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYHQfnhuUUN3ME2yMlc2OzhzIN88US=>NHz0XFFUSU6JRWK=
NCI-H1092MkK0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTJwOUWzPVQh|ryPM2XubHNCVkeHUh?=
KM-H2M3LBcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\Td213UUN3ME2zMlY2Ozl4IN88US=>NVL5emxqW0GQR1XS
KG-1NXrue4hwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LmUGlEPTB;Mz63NVY5QCEQvF2=NYXIS5hKW0GQR1XS
D-283MEDNESwNnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3\OSmlEPTB;Mz63OVg4KM7:TR?=NGjyeJlUSU6JRWK=
LU-65M2mzT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MmLETWM2OD12LkGxOFg2KM7:TR?=MX\TRW5ITVJ?
MSTO-211HNYLTS4EzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHrIcmZKSzVyPUSuNVg5QThizszNNGTZc3JUSU6JRWK=
NCI-H2081MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnqTWM2OD12LkK5NVc1KM7:TR?=MofzV2FPT0WU
D-247MGNXflUZA4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYDDdW5oUUN3ME20MlQ{OTlzIN88US=>MXjTRW5ITVJ?
P31-FUJNVj5TGlqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWTJR|UxRTRwNEWwNVkh|ryPMX\TRW5ITVJ?
DMS-79NEfnO5dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoXvTWM2OD12LkmzNVg{KM7:TR?=M1u5dXNCVkeHUh?=
KASUMI-1MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXOwdmFIUUN3ME20Mlk4PTB7IN88US=>MXXTRW5ITVJ?
JVM-3M2SxXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NWHsOJRHUUN3ME21MlI2ODF2IN88US=>NILw[WZUSU6JRWK=
LAN-6NXrCUZR2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYPBd3Q6UUN3ME21MlUyPzN4IN88US=>MVzTRW5ITVJ?
DJM-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XUU2lEPTB;NT61OlAzQSEQvF2=MlXuV2FPT0WU
JVM-2M2Wxcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYrJR|UxRTVwNkewPVIh|ryPM13wdXNCVkeHUh?=
U-87-MGMnLQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NW\ETI1lUUN3ME21Mlg6QTZ2IN88US=>NUjI[INmW0GQR1XS
SHP-77MkXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlrlTWM2OD13Lkm0PVI5KM7:TR?=M4fu[HNCVkeHUh?=
RPMI-8866NXi5WpZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlvJTWM2OD14LkK3NFE{KM7:TR?=MXjTRW5ITVJ?
ES7NYXiPI86T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGfkW2dKSzVyPU[uN|k6OjRizszNMXfTRW5ITVJ?
WSU-NHLMnLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWnJR|UxRTZwNUG2NFkh|ryPMUfTRW5ITVJ?
CAS-1NV;VV|hXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXvJR|UxRTdwMEm3OFkh|ryPNUPKNppQW0GQR1XS
MHH-NB-11NUPZXXpGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml3xTWM2OD16LkKzNVUzKM7:TR?=NVLLTGd7W0GQR1XS
ES5M3LFZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVPJR|UxRTlwNUKyPFYh|ryPMVzTRW5ITVJ?
HDLM-2NWPQR4lMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoraTWM2OD17Lkm1PVAzKM7:TR?=MV7TRW5ITVJ?
NCI-H2171MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1PJS2lEPTB;MUCuOVkzPyEQvF2=NIfQRXBUSU6JRWK=
LNCaP-Clone-FGCNHrXOmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGfJfJVKSzVyPUGxMlM4OThizszNNGe1dZFUSU6JRWK=
NCI-H1395Mn;ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPpTWM2OD1zMj6yOlk6KM7:TR?=NHXvW29USU6JRWK=
NCI-H1436Mn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFi2PHFKSzVyPUGzMlMyQTVizszNMXfTRW5ITVJ?
RCC10RGBM364NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYjRbVRnUUN3ME2xN{4{OjJzIN88US=>NXjqRmJlW0GQR1XS
SW684NFzt[2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlrLTWM2OD1zMz65O|k4KM7:TR?=M2rXW3NCVkeHUh?=
NCI-H1650MkDhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYXDXmZpUUN3ME2xOU4xPDR5IN88US=>Ml3uV2FPT0WU
EW-13NInEcFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTF3LkKwNlEh|ryPNGHTVYFUSU6JRWK=
EC-GI-10NVn0VY1LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGri[XRKSzVyPUG1Mlg3PDRizszNM{P2XXNCVkeHUh?=
CHP-126MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2j2bmlEPTB;MUeuNVkyQCEQvF2=MVnTRW5ITVJ?
NCI-H226NXGwSYtlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\1TWM2OD1zOD6wOFA{KM7:TR?=NHjpV4VUSU6JRWK=
NCI-H1838Ml;SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoHpTWM2OD1{MD6xPFQ5KM7:TR?=MoTRV2FPT0WU
EW-11MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfNTWM2OD1{ND6yO|E5KM7:TR?=NWHWc4V{W0GQR1XS
EB2NGW0eI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLYcoY{UUN3ME2zNU42OzF6IN88US=>MY\TRW5ITVJ?
D-502MGNV\aNZFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUHJR|UxRTR|LkmyNlkh|ryPM4DWSHNCVkeHUh?=
U-698-MMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXPJR|UxRTR6Lki2O|Eh|ryPNUC3TI1EW0GQR1XS
ES3NGj1ToVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnnDTWM2OD12OT6zPFk{KM7:TR?=NWrzeII1W0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo Torin1 is efficacious at a dose of 20 mg/kg in a U87MG xenograft model and demonstrates good pharmacodynamic inhibition of downstream effectors of mTOR in tumor and peripheral tissues. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

mTORC1 and mTORC2 in Vitro Kinase Assays To produce soluble mTORC1, HEK-293T cell lines that stably express N-terminally FLAG-tagged Raptor are generated using vesicular stomatitis virus G-pseudotyped MSCV retrovirus. For mTORC2, similar HeLa cells that stably express N-terminally FLAG-tagged Protor-1 are generated. Both complexes are purified by lysing cells in 50 mm HEPES, pH 7.4, 10 mm sodium pyrophosphate, 10 mm sodium β-glycerophosphate, 100 mm NaCl, 2 mm EDTA, 0.3% CHAPS. Cells are lysed at 4 °C for 30 min, and the insoluble fraction is removed by microcentrifugation at 13,000 rpm for 10 min. Supernatants are incubated with FLAG-M2 monoclonal antibody-agarose for 1 h and then washed three times with lysis buffer and once with lysis buffer containing a final concentration of 0.5 M NaCl. Purified mTORC1 is eluted with 100 μg/mL 3×FLAG peptide in 50 mm HEPES, pH 7.4, 100 mm NaCl. Eluate can be aliquoted and stored at -80 °C. Substrates S6K1 and Akt1 are purified. Kinase assays are performed for 20 min at 30 °C in a final volume of 20 μL consisting of the kinase buffer (25 mm HEPES, pH 7.4, 50 mm KCl, 10 mm MgCl2, 500 μm ATP) and 150 ng of inactive S6K1 or Akt1 as substrates. Reactions are stopped by the addition of 80 μL of sample buffer and boiled for 5 min. Samples are subsequently analyzed by SDS-PAGE and immunoblotting.

Cell Assay: [1]

Cell lines MEFs
Concentrations ~250 nM
Incubation Time 4 days
Method Cell viability is assessed with the CellTiter-Glo Luminescent Cell Viability Assay. On Day 0, 96-well plates are seeded with 500 cells per well and grown overnight. On Day 1, cells are treated with the appropriate compounds and subsequently analyzed on Days 3-5. For analysis, plates are incubated for 60 min at room temperature; 50 μL of CellTiter-Glo reagent is added to each well, and plates are mixed on an orbital shaker for 12 min. Luminescence is quantified on a standard plate luminometer.

Animal Study: [2]

Animal Models U87MG xenograft model
Formulation Torin1 powder is first dissolved at 25 mg/mL in 100% N-methyl-2-pyrrolidone and subsequently diluted 1:4 with sterile 50% PEG400 to a final concentration of 5 mg/mL
Dosages 20 mg/kg
Administration Administered via i.p. once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Thoreen CC, et al, J Biol Chem, 2009, 284(12), 8023-8032.

[2] Liu Q, et al, J Med Chem, 2010, 53(19), 7146-7155.

view more

Chemical Information

Download Torin 1 SDF
Molecular Weight (MW) 607.62
Formula

C35H28F3N5O2

CAS No. 1222998-36-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 2 mg/mL (3.29 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG 400+0.5% Tween80+5% Propylene glycol 30mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Benzo[h]-1,6-naphthyridin-2(1H)-one, 1-[4-[4-(1-oxopropyl)-1-piperazinyl]-3-(trifluoromethyl)phenyl]-9-(3-quinolinyl)-

Customer Product Validation(4)


Click to enlarge
Rating
Source Mol Cell Biol 2014 34(24), 4474-84. Torin 1 purchased from Selleck
Method Immunoprecipitation
Cell Lines HeLa cells
Concentrations 1 mM
Incubation Time 1 h
Results The specificity of the reaction was further demonstrated by the loss of SENP3 phosphorylation as well as mTOR autophosphorylation upon the addition of the mTOR inhibitor Torin1.

Click to enlarge
Rating
Source Am J Pathol 2014 184(1), 214-29. Torin 1 purchased from Selleck
Method Western blot
Cell Lines Huh-7.5 cells
Concentrations 0-100 nM
Incubation Time 24 h
Results To investigate the relationship between ER stress and autophagy and IFN receptors, it first induced ER stress and autophagy response with the known inducers TG and Torin 1, respectively, in uninfected Huh-7.5 cells. It performed TG and Torin 1 titration experiments in HCV-infected and uninfected Huh-7.5 cells to compare IFNAR1 expression by Western blotting.

Click to enlarge
Rating
Source Biochem Biophys Res Commun 2014 10.1016/j.bbrc.2014.05.047. Torin 1 purchased from Selleck
Method Western blot
Cell Lines HepG2 cells
Concentrations 0.1 nM
Incubation Time 24 h
Results When autophagy was induced by treatment of mTOR inhibitors PP242 or Torin1, the amount of LC3-II increased.

Click to enlarge
Rating
Source Lim Hsiu Kim, Lina from National University of Singapore. Torin 1 purchased from Selleck
Method ELISA
Cell Lines C6
Concentrations 10 nM
Incubation Time 1 h
Results

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related mTOR Products

  • MHY1485

    MHY1485 is a potent, and cell-permeable mTOR activator, and also potently inhibits autophagy.

  • CHIR-99021 (CT99021)

    CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively.

  • Dorsomorphin

    Dorsomorphin is a potent, reversible, selective AMPK inhibitor with Ki of 109 nM in cell-free assays, exhibiting no significant inhibition of several structurally related kinases including ZAPK, SYK, PKCθ, PKA, and JAK3. Also inhibits type I BMP receptor activity.

  • Rapamycin (Sirolimus)

    Rapamycin (Sirolimus) is a specific mTOR inhibitor with IC50 of ~0.1 nM HEK293 cells.

  • Everolimus (RAD001)

    Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM in a cell-free assay.

  • AZD8055

    AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM in MDA-MB-468 cells with excellent selectivity (∼1,000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.

    Features:First drug to inhibit both types of mTOR protein.

  • Temsirolimus (CCI-779, NSC 683864)

    Temsirolimus (CCI-779, NSC 683864) is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay.

  • INK 128 (MLN0128)

    INK 128 (MLN0128) is a potent and selective mTOR inhibitor with IC50 of 1 nM in cell-free assays; >200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes (vs Rapamycin). Phase 1.

  • Tacrolimus (FK506)

    Tacrolimus (FK506) is a 23-membered macrolide lactone, it reduces peptidyl-prolyl isomerase activity in T cells by binding to the immunophilin FKBP12 (FK506 binding protein) creating a new complex.

  • KU-0063794

    KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM in cell-free assays; no effect on PI3Ks.

Recently Viewed Items

Tags: buy Torin 1 | Torin 1 supplier | purchase Torin 1 | Torin 1 cost | Torin 1 manufacturer | order Torin 1 | Torin 1 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us